Meningococcal 360 disease, N Engl J Med, vol.344, pp.1378-1388, 2001. ,
, , p.362
, The Global, vol.363, 2011.
, Meningococcal Initiative: recommendations for reducing the global burden of 364 meningococcal disease, Vaccine, vol.29, pp.3363-3371
Global epidemiology of meningococcal 366 disease, Vaccine, vol.27, pp.51-63, 2009. ,
A multi-component 368 meningococcal serogroup B vaccine (4CMenB): the clinical development program, 2014. ,
, Drugs, vol.74, pp.15-30
Taha 371 MK. 2013. Could the multicomponent meningococcal serogroup B vaccine (4CMenB, p.372 ,
, control Neisseria meningitidis capsular group X outbreaks in Africa? Vaccine, vol.31, pp.1113-373
Development of a group A meningococcal 375 conjugate vaccine, MenAfriVac(TM), Hum Vaccin Immunother, vol.8, pp.715-724, 2012. ,
Meningococcal meningitis: unprecedented 378 incidence of serogroup X-related cases in 2006 in Niger, Clin Infect Dis, vol.44, pp.657-663, 2007. ,
, , p.380
Neisseria meningitidis serogroups W135 and A were equally prevalent, vol.381, p.17, 2002. ,
, among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and 382
, J Clin Microbiol, vol.40, pp.1083-1084
, , vol.384
Epidemiological changes in meningococcal meningitis in Niger from 385 2008 to 2011 and the impact of vaccination, BMC Infect Dis, vol.13, p.576, 2013. ,
Laboratory evaluation of a rapid 387 diagnostic test for Neisseria meningitidis serogroup A, Trans R Soc Trop Med Hyg, 2013. ,
Scaling up of 389 PCR-based surveillance of bacterial meningitis in the African meningitis belt: 390 indisputable benefits of multiplex PCR assay in Niger, Trans R Soc Trop Med Hyg, vol.100, pp.391-677, 2006. ,
New rapid 393 diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y, PLoS Med, vol.3, p.337, 2006. ,
, Reporting on 2010 surveillance data and 2011 epidemic intelligence data, vol.397, 2012.
, , p.399
,
, , 2013.
, Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by 402 meningococcal serogroup X, Proc Natl Acad Sci, vol.110, pp.19077-19082
Neisseria 404 gonorrhoeae. I. Virulence Genetically Linked to Clonal Variation, J Bacteriol, vol.85, pp.1274-405, 1963. ,
Comparison of three latex 407 agglutination kits and counterimmunoelectrophoresis for the detection of bacterial 408 antigens in a pediatric population, Pediatr Infect Dis J, vol.6, pp.630-634, 1987. ,
Neisseria meningitidis group B serosubtyping using 410 monoclonal antibodies in whole-cell ELISA, Microb Pathog, vol.4, pp.27-32, 1988. ,
, , p.412
, , 2005.
, Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain 414 reaction testing, Clin Infect Dis, vol.40, pp.17-25
Riou 416 JY. 1991. Production of polyclonal and monoclonal antibodies against group A, B, and C 417 capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents, J 418 Clin Microbiol, vol.29, pp.1447-1452 ,
, , p.420
Characterization of 421 size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and 422 development of an assay for quantification of human antibodies, Vaccine, vol.30, pp.5812-5823, 2012. ,
Phosphorylation and functional analysis of PilA, a protein 424 involved in the transcriptional regulation of the pilin gene in Neisseria gonorrhoeae, Mol 425 Microbiol, vol.15, pp.667-677, 1995. ,
, , p.427
Development and testing of a rapid diagnostic test for 428 bubonic and pneumonic plague, Lancet, vol.361, pp.211-216, 2003. ,
Users' guides to the medical literature. III. How 430 to use an article about a diagnostic test. B. What are the results and will they help me in 431 caring for my patients? The Evidence-Based Medicine Working Group, JAMA, vol.271, pp.432-703, 1994. ,
The diagnostic odds ratio: 434 a single indicator of test performance, J Clin Epidemiol, vol.56, pp.1129-1135, 2003. ,
A coefficient of agreement for nominal scales, Edu Psychol Measur, vol.20, pp.37-436, 1960. ,
Early treatment with parenteral 438 penicillin in meningococcal disease, Bmj, vol.305, pp.143-147, 1992. ,
, Table 1. Strains used in the study and their characteristics 450 Strain reference Serogroup:serotype/serosub-type 21525* A:4:P1.9 21526 A:4:P1.9 19256 B:NT:P1.5,2 19257 B:2a:P1.5, vol.5